Cinemark Holdings, Inc.
CNK
$31.48
-1.44%
Cinemark Holdings, Inc. is a leading operator in the motion picture exhibition industry, generating revenue primarily from box office receipts and concession sales in the U.S. and international markets. As one of the largest theater chains in the U.S., Cinemark distinguishes itself through its scale and diversified revenue streams including screen advertising and rental income. The current investor narrative centers on the company's post-pandemic recovery, with strong box office performance and a $300 million buyback signaling management confidence, though concerns about industry headwinds and competition from streaming persist.…
CNK
Cinemark Holdings, Inc.
$31.48
Related headlines
CNK 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cinemark Holdings, Inc.'s 12-month outlook, with a consensus price target around $35.18 and implied upside of +11.8% versus the current price.
Average Target
$35.18
0 analysts
Implied Upside
+11.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$30 - $38
Analyst target range
Cinemark is covered by 11 analysts, with a consensus recommendation of 'buy' (mean recommendation of 1.73 on a 1-5 scale where 1 is strong buy). The average target price is $35.45, implying an upside of 16.5% from the current price of $30.42. The distribution leans bullish, with no sell ratings indicated. The target range spans from $30.00 (low) to $40.00 (high). The low target of $30.00 is slightly below the current price, suggesting some analysts see limited upside or downside risk. The high target of $40.00 implies a 31.5% upside, likely assuming strong box office recovery and margin expansion. The spread between low and high is $10.00 (33% of the low), indicating moderate uncertainty. Recent news highlights a $300 million buyback and institutional backing, which supports the bullish consensus. However, the lack of detailed ratings data limits further analysis of recent upgrades or downgrades.
Bulls vs Bears: CNK Investment Factors
Cinemark presents a mixed picture: strong analyst support, a cheap forward valuation, and a robust buyback program are countered by extreme leverage, liquidity risks, and recent price weakness. The bull case hinges on successful earnings growth and box office recovery, while the bear case focuses on financial fragility and industry disruption. Currently, the evidence slightly favors the bulls given the 16.5% upside to the average target and the cheap PS ratio, but the high debt level is the single most important tension—if cash flows fail to cover debt service, the thesis could unravel quickly.
Bullish
- Strong Buyback and Institutional Confidence: Cinemark announced a $300 million buyback program, signaling management's confidence in the company's valuation and future cash flows. Additionally, a new $7 million institutional bet underscores external conviction, reinforcing the bullish thesis.
- Attractive Forward Valuation: With a forward P/E of 12.39x, Cinemark trades at a significant discount to its trailing P/E of 19.69x, implying the market expects robust earnings growth. The average analyst target of $35.45 offers 16.5% upside from the current price of $30.42.
- Strong Revenue Recovery Trajectory: Estimated next fiscal year revenue of $4.09 billion reflects continued post-pandemic recovery. The low PS ratio of 0.86x suggests the stock is cheap relative to sales, providing a margin of safety if earnings growth materializes.
- High ROE and Positive Net Income: Cinemark's ROE of 34.11% is exceptionally high, indicating efficient use of equity capital. The company is profitable with trailing EPS of $0.05, and net margin of 4.44% supports the recovery narrative.
Bearish
- Extreme Financial Leverage: The debt-to-equity ratio of 9.34 is very high, indicating significant financial risk. High leverage amplifies earnings volatility and could strain cash flows if box office recovery stalls or interest rates remain elevated.
- Liquidity Concerns from Low Current Ratio: The current ratio of 0.71 means current liabilities exceed current assets, posing a liquidity risk. This could force the company to rely on external financing or asset sales to meet short-term obligations.
- Recent Price Weakness and Momentum Divergence: The stock has declined 8.12% in the past month, underperforming the S&P 500 by 8.43%. This short-term weakness contrasts with the 6-month gain of 27.12%, suggesting potential profit-taking or fading momentum.
- Industry Headwinds from Streaming Competition: The rise of streaming services continues to pressure movie theater attendance. AMC's recent struggles with dilution and cash flow issues highlight sector-wide challenges that could also affect Cinemark's recovery.
CNK Technical Analysis
Cinemark's stock has been in a strong uptrend over the past year, with a 1-year price change of +1.43% but a more pronounced 6-month gain of +27.12%. The current price of $30.42 sits at 87.6% of its 52-week range ($21.60 to $34.73), indicating the stock is near the upper end of its range, reflecting robust momentum but also potential overextension. This positioning near the 52-week high suggests bullish sentiment, though caution is warranted as the stock may be pricing in optimistic expectations. Short-term momentum has diverged from the longer-term trend: the 1-month price change is -8.12%, while the 3-month change is +1.37%, and the 6-month change is +27.12%. The recent pullback from the June high of $34.01 to $30.42 represents a decline of about 10.6%, which could signal a temporary correction within an uptrend or the start of a reversal. The relative strength index (RSI) is not provided, but the volume data (2,448,541 shares) and short ratio of 3.56 suggest moderate bearish sentiment. The 52-week low of $21.60 provides strong support, while the 52-week high of $34.73 is the key resistance level. A breakout above $34.73 would signal a continuation of the uptrend, potentially targeting new highs, while a breakdown below $21.60 would indicate a bearish reversal. With a beta of 0.983, Cinemark's volatility is roughly in line with the market, meaning it does not amplify market moves significantly, which is favorable for risk management.
Beta
0.98
0.98x market volatility
Max Drawdown
-32.8%
Largest decline past year
52-Week Range
$22-$35
Price range past year
Annual Return
+5.8%
Cumulative gain past year
| Period | CNK Return | S&P 500 |
|---|---|---|
| 1m | -6.8% | +0.2% |
| 3m | +10.3% | +5.2% |
| 6m | +30.5% | +8.6% |
| 1y | +5.8% | +19.0% |
| ytd | +33.8% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CNK Fundamental Analysis
Cinemark's revenue trajectory appears to be recovering, though specific quarterly revenue figures are not provided. The estimated revenue for the next fiscal year is $4.09 billion, with a low estimate of $4.01 billion and high of $4.18 billion, indicating expected growth. The company's net margin is 4.44%, and gross margin is 18.55%, which are typical for the exhibition industry. The operating margin of 10.97% suggests improving operational efficiency. Net income is positive, with EPS of $0.05 (trailing twelve months), and the company is profitable. The ROE of 34.11% is exceptionally high, indicating strong returns on equity, though this is partly due to high leverage. The debt-to-equity ratio of 9.34 is very high, signaling significant financial leverage. The current ratio of 0.71 indicates potential liquidity concerns, as current liabilities exceed current assets. Free cash flow data is not provided, but the PCF ratio of 6.78 suggests the company generates positive cash flow. The high debt levels and low current ratio are risks, but the strong ROE and positive net income support the investment case if cash flow generation remains robust.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CNK Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 19.69x, while the forward P/E is 12.39x, implying that the market expects significant earnings growth. The gap between trailing and forward P/E suggests that earnings are expected to increase substantially, which aligns with the recovery narrative. Compared to the industry average (not provided), Cinemark's P/E of 19.69x may be at a premium or discount depending on the sector. The PS ratio of 0.86x is low, indicating the stock is cheap relative to sales. The EV/EBITDA of 11.79x is moderate. Historical ratios are not available, but the current P/E is likely below historical averages given the post-pandemic recovery, suggesting the stock may still be undervalued relative to its own history. The PEG ratio is negative (-0.37), which is not meaningful due to negative earnings growth expectations, but the forward P/E of 12.39x implies a PEG of around 0.5 if earnings grow at 25%, indicating potential undervaluation.
PE
19.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Cinemark's balance sheet is highly leveraged with a debt-to-equity ratio of 9.34, which amplifies the impact of any earnings shortfall. The current ratio of 0.71 indicates that current liabilities exceed current assets by a significant margin, raising concerns about the company's ability to meet short-term obligations without external financing. Additionally, the net margin of 4.44% is thin, leaving little room for error if revenue growth stalls or costs rise. The reliance on box office revenue, which is inherently volatile and seasonal, adds further operational risk.
Market & Competitive Risks: The stock's beta of 0.983 suggests market-like volatility, but its recent 1-month relative strength of -8.43% versus the S&P 500 indicates underperformance. The entertainment industry faces secular headwinds from streaming services, which could permanently reduce theater attendance. Recent news about AMC's dilution and cash flow problems highlights sector-wide challenges that could spill over to Cinemark. Valuation risk is present as the trailing P/E of 19.69x is not cheap in absolute terms, and any disappointment in earnings could lead to multiple compression.
Worst-Case Scenario: In a severe downturn, a combination of weak box office performance, rising interest rates, and inability to service debt could force Cinemark to cut its dividend or raise capital at dilutive terms. The 52-week low of $21.60 represents a potential downside of 29% from the current price of $30.42. If the company faces a liquidity crisis, the stock could revisit that level or lower, resulting in a loss of approximately 29% or more. The historical max drawdown of -32.83% provides a reference for the magnitude of potential losses in adverse conditions.